PNC Financial Services Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-273
| Closed | -$5K | – | 4160 |
|
|
2020
Q2 | $5K | Sell |
273
-100
| -27% | -$1.39K | ﹤0.01% | 3658 |
|
|
2020
Q1 | $3K | Buy |
373
+259
| +227% | +$3.23K | ﹤0.01% | 3709 |
|
|
2019
Q4 | $3K | Sell |
114
-196
| -63% | -$5.41K | ﹤0.01% | 3758 |
|
|
2019
Q3 | $8K | Buy |
310
+73
| +31% | +$2.05K | ﹤0.01% | 3651 |
|
|
2019
Q2 | $6K | Buy |
237
+101
| +74% | +$3.17K | ﹤0.01% | 3721 |
|
|
2019
Q1 | $4K | Hold |
136
| – | – | ﹤0.01% | 3807 |
|
|
2018
Q4 | $2K | Sell |
136
-393
| -74% | -$8.08K | ﹤0.01% | 3905 |
|
|
2018
Q3 | $15K | Hold |
529
| – | – | ﹤0.01% | 3549 |
|
|
2018
Q2 | $20K | Sell |
529
-111
| -17% | -$4.25K | ﹤0.01% | 3454 |
|
|
2018
Q1 | $21K | Buy |
640
+115
| +22% | +$5.05K | ﹤0.01% | 3429 |
|
|
2017
Q4 | $26K | Buy |
525
+18
| +4% | +$910 | ﹤0.01% | 3286 |
|
|
2017
Q3 | $28K | Buy |
507
+7
| +1% | +$411 | ﹤0.01% | 3218 |
|
|
2017
Q2 | $28K | Hold |
500
| – | – | ﹤0.01% | 3190 |
|
|
2017
Q1 | $20K | Hold |
500
| – | – | ﹤0.01% | 3304 |
|
|
2016
Q4 | $10K | Hold |
500
| – | – | ﹤0.01% | 3500 |
|
|
2016
Q3 | $12K | Buy |
500
+100
| +25% | +$2.35K | ﹤0.01% | 3436 |
|
|
2016
Q2 | $10K | Hold |
400
| – | – | ﹤0.01% | 3573 |
|
|
2016
Q1 | $8K | Hold |
400
| – | – | ﹤0.01% | 3668 |
|
|
2015
Q4 | $20K | Buy |
+400
| New | +$19.4K | ﹤0.01% | 3309 |
|
|
2015
Q2 | – | Sell |
-75
| Closed | -$3K | – | 4808 |
|
|
2015
Q1 | $3K | Sell |
75
-777
| -91% | -$26.7K | ﹤0.01% | 4215 |
|
|
2014
Q4 | $24K | Buy |
+852
| New | +$23.7K | ﹤0.01% | 3089 |
|
|
2014
Q2 | – | Sell |
-385
| Closed | -$10K | – | 3941 |
|
|
2014
Q1 | $10K | Buy |
+385
| New | +$10.3K | ﹤0.01% | 3075 |
|
PNC Financial Services Group's PTLA Position: Q3 2020 in Review
PNC Financial Services Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 273 shares — an estimated $5K sold.
PNC Financial Services Group first reported a position in PTLA in Q1 2014 and held it in 22 quarters. The position peaked at $28K in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- PNC Financial Services Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- PNC Financial Services Group sold 273 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $5K.
- PNC Financial Services Group first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 22 quarters.
- PNC Financial Services Group's Portola Pharmaceuticals, Inc. position peaked at $28K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on PNC Financial Services Group's 13F filing for Q3 2020, filed 6 Nov 2020.